Enveda Therapeutics
Clinical trials sponsored by Enveda Therapeutics, explained in plain language.
-
New eczema pill shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental pill called ENV-294 for adults with moderate-to-severe atopic dermatitis (eczema). About 200 participants will take either one of three doses of ENV-294 or a placebo daily for 12 weeks. Researchers will measure changes in eczema severity, symptoms…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New eczema pill shows promise in early trial
Symptom relief Recruiting nowThis study tests whether a new oral drug called ENV-294 can safely reduce eczema severity in adults with moderate-to-severe atopic dermatitis. Sixty participants will take either ENV-294 or a placebo pill daily for 12 weeks. Researchers will measure changes in skin symptoms and t…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New asthma pill shows promise in early trial
Symptom relief Recruiting nowThis study tests an experimental oral drug called ENV-294 in 50 adults with moderate-to-severe asthma who already use standard inhalers. Participants take either the drug or a placebo once daily for 12 weeks. The goal is to see if the drug improves asthma control and lung functio…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC